Replies to post #303037 on Bioelectronics Corp (BIEL)

[4toSchool]

Taking into consideration Deferred Revenue, the year-over-year change in sales as of 9-30-2022, is -$607,517, or -43%

Now, accounting for deferred revenue, the revenue variance between the 2022 3rd quarter versus 2021 3rd quarter is -$212,163, or -51%

It's getting worse

Time for a new CEO, but that time has likely passed, just like the value of BIEL.